Hotchkis & Wiley Capital Management LLC lessened its position in Herbalife Ltd (NYSE:HLF - Free Report) by 66.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 922,610 shares of the company's stock after selling 1,786,980 shares during the quarter. Hotchkis & Wiley Capital Management LLC owned 0.91% of Herbalife worth $7,962,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in HLF. Q Global Advisors LLC raised its position in Herbalife by 22.1% in the 1st quarter. Q Global Advisors LLC now owns 444,765 shares of the company's stock worth $3,838,000 after purchasing an additional 80,367 shares during the period. Algert Global LLC raised its holdings in shares of Herbalife by 50.0% in the first quarter. Algert Global LLC now owns 308,919 shares of the company's stock worth $2,666,000 after buying an additional 102,910 shares during the period. Caitong International Asset Management Co. Ltd lifted its stake in shares of Herbalife by 4,406.4% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 4,912 shares of the company's stock worth $42,000 after acquiring an additional 4,803 shares during the last quarter. Nuveen LLC purchased a new position in Herbalife during the 1st quarter valued at $2,526,000. Finally, Invesco Ltd. grew its position in Herbalife by 99.5% in the 1st quarter. Invesco Ltd. now owns 450,086 shares of the company's stock valued at $3,884,000 after acquiring an additional 224,457 shares during the last quarter.
Analysts Set New Price Targets
HLF has been the subject of a number of recent analyst reports. Wall Street Zen lowered shares of Herbalife from a "strong-buy" rating to a "buy" rating in a research note on Sunday, August 10th. Mizuho boosted their price objective on shares of Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a research report on Monday, July 28th. Finally, Citigroup dropped their target price on shares of Herbalife from $13.00 to $11.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $11.50.
Get Our Latest Analysis on HLF
Herbalife Trading Down 3.2%
Shares of HLF traded down $0.31 during trading hours on Thursday, hitting $9.18. The company had a trading volume of 1,955,869 shares, compared to its average volume of 2,149,582. The company has a market capitalization of $946.03 million, a PE ratio of 2.89, a price-to-earnings-growth ratio of 0.28 and a beta of 0.85. Herbalife Ltd has a one year low of $5.04 and a one year high of $10.83. The company's fifty day moving average price is $9.32 and its two-hundred day moving average price is $8.09.
Herbalife (NYSE:HLF - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.06. The company had revenue of $1.26 billion for the quarter, compared to analyst estimates of $1.27 billion. Herbalife had a negative return on equity of 27.36% and a net margin of 6.59%.The firm's quarterly revenue was down 1.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.54 earnings per share. Analysts forecast that Herbalife Ltd will post 1.57 earnings per share for the current year.
About Herbalife
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Further Reading

Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.